Cover Image
市場調查報告書

無針頭藥物遞輸的全球市場的未來展望 (到2020年)

Global Needle Free Drug Delivery Market Outlook 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 330510
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
無針頭藥物遞輸的全球市場的未來展望 (到2020年) Global Needle Free Drug Delivery Market Outlook 2020
出版日期: 2015年05月01日 內容資訊: 英文 80 Pages
簡介

無針頭藥物遞輸技術,是能不弄傷皮膚將藥物送達人體的創新技術。這數年,無針頭藥物遞輸產業乘上急劇成長的趨勢,帶給參與企業巨大的市場機會。良好的人口結構和經濟形勢,認知度的上升也提供支撐,全球無針頭藥物遞輸市場規模更為擴大。還有活躍的企業合併、收購 (M&A) 活動,及最新設備 (微針頭 (顯微針)、貼片、滾筒等) 的開發、引進,新企業進入的現象,促進市場進一步擴大。

本報告提供全球的無針頭藥物遞輸 (藥物輸送) 市場相關分析、市場整體結構最新趨勢、主要市場促進與阻礙因素、全球各國的法規與支援策略、今後的市場趨勢預測、各技術、各用途、各地區的詳細趨勢、今後的產業發展的方向性、主要企業簡介等調查。

第1章 分析師的見解

第2章 分析方法

第3章 推動市場要素

  • 慢性疾病的發病者數的增加
  • 可得性的改善
  • 傳統藥物遞送設備的優點
  • 新興國家市場的成長

第4章 市場課題

  • 價格高
  • 檢驗、規定有關的課題
  • 認知度低

第5章 法規環境

  • 美國
  • 歐洲
  • 日本
  • 中國
  • 印度

第6章 無針頭藥物遞輸市場未來展望 (到2020年)

  • 目前市場規模和未來預測

第7章 市場明細

  • 各技術
    • 口服式藥物傳送系統
    • 吸入式藥物傳送系統
    • 經皮式藥物傳送系統
    • 噴氣式注射器式藥物傳送系統
    • 微針頭式藥物傳送系統
  • 各用途
  • 各地區

第8章 產業趨勢

  • 發展中國家引進低成本吸入器
  • 最新型的乾燥粉末吸入器的開發
  • 口服式藥物傳送系統的電子化
  • 市場重組

第9章 企業簡介

  • Mylan Inc.
  • 3M (MMM)
  • Novatis
  • AstraZeneca Plc
  • Antares Pharma, Inc.
  • GlaxoSmithKline Plc (GSK)
  • Sanofi
  • Boehringer Ingelheim GmbH
  • Merck & Co.

圖表一覽

目錄

The needle-free drug delivery technology is an innovative technique to deliver drugs into a person's body without piercing the skin. The global needle-free drug delivery industry has been riding the tidal waves for the past few years, growing swiftly and presenting ample opportunities to the industry's players. With favorable demographics, positive eco-financial dynamics, and rising awareness, the global needle-free drug delivery market is poised to scale newer acmes. Moreover, augmented M&A activity in the industry, introduction of novel needle-free drug delivery devices, like micro needles, patch and roller, and entry of new players are set to further boost the market's growth.

The latest research by RNCOS titled, "Global Needle Free Drug Delivery Market Outlook 2020", unfolds the market dynamics of the needle-free drug delivery market. In this report, the global needle-free drug delivery industry has been split into five distinct segments viz.: Jet injectors, Transdermal Patches, Micro Needles, and Oral and Inhalation drug delivery, with their current and future outlook to 2020 depicted. The transdermal patches and inhalation drug delivery system markets are further divided into sub-segments, with each segment scrutinized in detail. The report identifies and highlights the segments that offer the maximum opportunity for growth in the global market.

Our industry analysts studied all the facets of the global needle-free drug delivery market to portray a crystal clear picture of the current as well as expected future market outlook. Major drivers and trends have been identified that will act as catalysts towards boosting the industry's growth along with roadblocks hindering the market's growth. The study also delves into the regulatory environment affecting the needle-free drug delivery devices in a number of countries.

It further highlights the competitive landscape of the global needle-free drug delivery market, describing the business, financials, strengths and weaknesses, and recent developments of major industry players, thus helping the reader to gain a crucial insight into the key market players' performances and strategies for growth. Holistically, the research provides all the prerequisite information for clients looking to make a debut in this industry and facilitates them to formulate schemes while going for an investment/partnership in the global needle-free drug delivery industry.

Table of Contents

1. Analyst View

2. Research Methodology

3. Drivers

  • 3.1 Increasing Incidence of Chronic Diseases
  • 3.2 Increased Affordability
  • 3.3 Benefits over Conventional Drug Delivery Devices
  • 3.4 Expansion in Emerging Markets

4. Challenges

  • 4.1 High Prices
  • 4.2 Testing and Regulatory Issues
  • 4.3 Low Awareness

5. Regulatory Landscape

  • 5.1 US
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China
  • 5.5 India

6. Needle Free Drug Delivery Market Outlook to 2020

  • 6.1 Current Market size and Future Outlook

7. Market Segmentation

  • 7.1 By Technology
    • 7.1.1 Oral Drug Delivery System
    • 7.1.2 Inhaler Drug Delivery System
    • 7.1.3 Transdermal Drug Delivery System
    • 7.1.4 Jet injector Drug Delivery System
    • 7.1.5 Micro Needle Drug Delivery System
  • 7.2 By Application
  • 7.3 By geography

8. Industry Trends

  • 8.1 Introduction of Low Cost Inhalers for Developing Countries
  • 8.2 Innovation in Advanced Dry Powder Inhalers
  • 8.3 Oral Drug Delivery System goes Electrical
  • 8.4 Consolidation in the Market

9. Competitor Profiles

  • 9.1 Mylan Inc.
  • 9.2 3M (MMM)
  • 9.3 Novatis
  • 9.4 AstraZeneca Plc
  • 9.5 Antares Pharma, Inc.
  • 9.6 GlaxoSmithKline Plc (GSK)
  • 9.7 Sanofi
  • 9.8 Boehringer Ingelheim GmbH
  • 9.9 Merck & Co.

List of Figures:

  • Figure 6-1: Global - Needle Free Drug Delivery Market (Billion US$), 2014-2020
  • Figure 7-1: Global - Needle Free Drug Delivery Market by Technology (%), 2014
  • Figure 7-2: Global - Oral Drug Delivery Market (Billion US$), 2014-2020
  • Figure 7-3: Global - Inhaler Drug Delivery Market (Billion US$), 2014-2020
  • Figure 7-4: Global - Inhaler Drug Delivery Market by Segment (%), 2014
  • Figure 7-5: Global - Inhaled Drug Delivery Market by Players (%), 2013
  • Figure 7-6: Global - Transdermal Drug Delivery Market (Billion US$), 2014-2020
  • Figure 7-7: Global - Transdermal Drug Delivery Market by Sub-Segment (%), 2013
  • Figure 7-8: Global - Jet Injectors Market (Million US$), 2014-2020
  • Figure 7-9: Global - Jet Injectors Market by Players (%), 2014
  • Figure 7-10: Global - Needle Free Drug Delivery Market by Application (%), 2014
  • Figure 7-11: Global - Needle Free Drug Delivery Market by Region (%), 2014
  • Figure 9-1: Mylan - Breakup of Revenue by Geography (%), 2014
  • Figure 9-2: 3M - Breakup of Revenue by Geography (%), 2014
  • Figure 9-3: Novartis - Breakup of Revenue by Geography (%), 2014
  • Figure 9-4: AstraZeneca Plc - Breakup of Revenue by Geography (%), 2014
  • Figure 9-5: Antares Pharma Inc. - Breakup of Revenue by Geography (%), 2014
  • Figure 9-6: GlaxoSmithKline Plc - Breakup of Revenue by Geography (%), 2014
  • Figure 9-7: Sanofi - Breakup of Revenue by Geography (%), 2014
  • Figure 9-8: Boehringer Ingelheim GmbH - Breakup of Revenue by Geography (%), 2013
  • Figure 9-9: Merck & Co - Breakup of Revenue by Geography (%), 2014

List of Tables:

  • Table 7-1: Oral Drug Delivery - Pipeline Analysis (2014)
  • Table 7-2: Inhaled Drug Delivery - Pipeline Analysis (2014)
  • Table 7-3: Transdermal Drug Delivery - Pipeline Analysis (2014)
  • Table 7-4: Jet Injectors Drug Delivery - Pipeline Analysis (2014)
  • Table 7-5: Micro Needles Drug Delivery - Pipeline Analysis (2014)
  • Table 8-1: Recent M&A in the Needle Free Drug Delivery Industry (2014)
  • Table 9-1: Mylan - Key Financials (Million US$), 2012-2014
  • Table 9-2: Mylan - Strengths and Weaknesses
  • Table 9-3: 3M - Key Financials (Million US$), 2012-2014
  • Table 9-4: 3M - Strengths and Weaknesses
  • Table 9-5: Novartis - Key Financials (Million US$), 2012-2014
  • Table 9-6: Novartis - Strengths and Weaknesses
  • Table 9-7: AstraZeneca Plc - Key Financials (Million US$), 2012-2014
  • Table 9-8: Astrazeneca - Strengths and Weaknesses
  • Table 9-9: Antares Pharma Inc. - Key Financials (Million US$), 2012-2014
  • Table 9-10: GlaxoSmithKline Plc - Key Financials (Million US$), 2012-2014
  • Table 9-11: GlaxoSmithKline - Strengths and Weaknesses
  • Table 9-12: Sanofi - Key Financials (Million US$), 2012-2014
  • Table 9-13: Sanofi - Strengths and Weaknesses
  • Table 9-14: Boehringer Ingelheim GmbH- Key Financials, (Million US$), 2011-2013
  • Table 9-15: Boehringer Ingelheim GmbH - Strengths and Weaknesses
  • Table 9-16: Merck & Co- Key Financials (Million US$), 2012-2014
  • Table 9-17: Merck & Co- Strengths and Weaknesses
Back to Top